RSS-Feed abonnieren

DOI: 10.1055/a-2803-4865
Groove area involvement predicts post-ERCP pancreatitis after 8-mm fully-covered metal stent placement in resectable pancreatic cancer
Autor*innen
Abstract
Background and study aims
Fully covered self-expandable metal stents (FCSEMSs) provide durable preoperative biliary drainage in pancreatic cancer but may increase risk of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). We evaluated whether groove involvement was an independent anatomical PEP risk factor and compared PEP incidence after 8-mm FCSEMS and plastic stent (PS) placement using propensity-score–based inverse probability of treatment weighting (IPTW).
Patients and methods
Sixty-two consecutive patients with resectable or borderline resectable pancreatic cancer and distal biliary strictures with naïve papillae underwent ERCPs between February 2015 and August 2024. An 8-mm FCSEMS or PS (7–11.5F) was placed. Independent PEP predictors were identified using multivariable Firth logistic regression. PEP incidence was compared between stent types after IPTW adjustment for age, sex, clinical stage, groove involvement, main pancreatic duct diameter, and prophylactic pancreatic-stent placement.
Results
Mean age was 73.3 ± 8.2 years (62.9% male). Groove-area extension was present in 21.0% of tumors. PEP occurred in six patients (9.7%), all after FCSEMS placement. Groove involvement independently predicted PEP (adjusted odds ratio, 14.7; 95% confidence interval, 2.26–95.9; P = 0.005). After IPTW, the weighted PEP rate remained higher with FCSEMS than PS (13.4% vs 0%; P = 0.011).
Conclusions
Groove-area tumor extension is an independent imaging-detectable PEP risk factor. Even after baseline difference adjustment, 8-mm FCSEMS placement was associated with a higher pancreatitis risk than PS placement. Pre-procedural groove involvement identification may guide stent selection and support selective prophylactic pancreatic stenting. However, further confirmation through larger prospective studies is required.
Publikationsverlauf
Eingereicht: 17. August 2025
Angenommen nach Revision: 02. Februar 2026
Accepted Manuscript online:
03. Februar 2026
Artikel online veröffentlicht:
26. Februar 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Shinya Kawaguchi, Eiji Nakatani, Tatsunori Satoh, Shodai Takeda, Yuichi Masui, Shinya Endo, Hideyuki Kanemoto. Groove area involvement predicts post-ERCP pancreatitis after 8-mm fully-covered metal stent placement in resectable pancreatic cancer. Endosc Int Open 2026; 14: a28034865.
DOI: 10.1055/a-2803-4865
-
References
- 1 Dumonceau JM, Tringali A, Papanikolaou IS. et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy 2018; 50: 910-930
- 2 Tol JA, van Hooft JE, Timmer R. et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut 2016; 65: 1981-1987
- 3 Song TJ, Lee JH, Lee SS. et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc 2016; 84: 814-821
- 4 Mandai K, Tsuchiya T, Kawakami H. et al. Fully covered metal stents vs plastic stents for preoperative biliary drainage in patients with resectable pancreatic cancer without neoadjuvant chemotherapy: A multicenter, prospective, randomized controlled trial. J Hepatobiliary Pancreat Sci 2022; 29: 1185-1194
- 5 Kawashima H, Hashimoto S, Ohno E. et al. Comparison of 8- and 10-mm diameter fully covered self-expandable metal stents: A multicenter prospective study in patients with distal malignant biliary obstruction. Dig Endosc 2019; 31: 439-447
- 6 Yamada R, Tanaka T, Shimada Y. et al. 6-mm vs 10-mm diameter fully covered self-expandable metal stents in patients with unresectable malignant distal bile duct stricture (COSMIC UNISON): study protocol for a multicenter, randomized controlled trial. Trials 2025; 26: 56
- 7 Ishiwatari H, Kobayashi Y, Kawaguchi S. et al. Assessment of safety and patency of 7-mm covered metal stents for preoperative biliary drainage in pancreatic cancer: prospective multicenter study. Endosc Int Open 2025; 13: a25031995
- 8 Song TJ, Lee JH, Lee SS. et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc 2016; 84: 814-821
- 9 Zeng C, Zhang Y, Yang H. et al. Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2022; 16: 141-154
- 10 Umemura M, Shimura E, Asai Y. et al. Dilated main pancreatic duct can be a negative predictor of pancreatitis related to biliary SEMS insertion across the papilla. Scand J Gastroenterol 2021; 56: 865-869
- 11 Japan Pancreas Society. Clinical practice guidelines for pancreatic cancer 2019. Tokyo: Kanehara & Co.; 2019
- 12 Isayama H, Hamada T, Yasuda I. et al. Tokyo criteria 2014 for transpapillary biliary stenting. Dig Endosc 2015; 27: 259-264
- 13 Nass KJ, Zwager LW, van der Vlugt M. et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085
- 14 Cotton PB, Garrow DA, Gallagher J. et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70: 80-88
- 15 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
- 16 Stolte M, Weiss W, Volkholz H. et al. A special form of segmental pancreatitis: “groove pancreatitis”. Hepatogastroenterology 1982; 29: 198-208
- 17 Brown NG, Sethi A. Palliative endoscopic therapy of pancreatic duct adenocarcinoma (PDAC). In: Doria C, Rogart JN. , ed. Hepato-Pancreato-biliary malignancies. Cham: Springer; 2022: 579-595
- 18 Sperna Weiland CJ, Akshintala VS, Singh A. et al. Preventive measures and risk factors for post-ERCP pancreatitis: an individual patient data meta-analysis. Dig Dis Sci 2024; 69: 4476-4488
- 19 Kozakai F, Ogawa T, Koshita S. et al. Fully covered self-expandable metallic stents versus plastic stents for preoperative biliary drainage in patients with pancreatic head cancer and the risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. DEN Open 2024; 4: e263
- 20 Tamura T, Itonaga M, Ashida R. et al. Covered self-expandable metal stents versus plastic stents for preoperative biliary drainage in patient receiving neo-adjuvant chemotherapy for borderline resectable pancreatic cancer: Prospective randomized study. Dig Endosc 2021; 33: 1170-1178
- 21 Mandai K, Tsuchiya T, Kawakami H. et al. Fully covered metal stents vs plastic stents for preoperative biliary drainage in patients with resectable pancreatic cancer without neoadjuvant chemotherapy: A multicenter, prospective, randomized controlled trial. J Hepato-Bil Pancreat Sci 2022; 29: 1185-1194
- 22 Toyonaga H, Hayashi T, Yamazaki H. et al. Efficacy of pancreatic duct stenting to prevent postendoscopic retrograde cholangiopancreatography pancreatitis after covered self-expandable metal stent deployment. Dig Endosc 2023; 35: 369-376
- 23 Phillip V, Pukitis A, Epstein A. et al. Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial. Endosc Int Open 2019; 7: E860-E868
